Lallemand Receives Patent Approval for TransFerm Yield+
March 27, 2015 - Issue #206View Full Issue
Lallemand Biofuels & Distilled Spirits (LBDS) and Mascoma, LLC recently announced that Lallemand has received a patent (US 8,956,851 B2) for the technology that is used inTransFerm Yield+. This invention provides for novel metabolic pathways that reduce or eliminate glycerol production and thereby increase ethanol yield by yeast or other microorganisms.
“We are extremely proud to have introduced these products into the marketplace. This drop-in, game-changing technology is one example of how our Mascoma business unit has produced real results” statedLBDS President Angus Ballard. “To be able to increase yields and thus increase the profitability of ethanol plants, at a time where margins are tight, is huge. This is just the beginning of a long line of Mascoma developed products that will be brought into the market by our team.”
“Development of this technology is the result of years of dedicated R&D effort by Mascoma,” stated Mascoma Executive Vice President Kevin Wenger. “We are quite pleased that theU.S. Patent Office has allowed the patent; we believe it shows how innovative and significant this new approach really is. TransFerm Yield+ is truly the first product of its kind to offer this type of step change technology in ethanol production.”
During the past three years, LBDS and Mascoma introduced TransFerm® and TransFerm® Yield+ yeasts into the ethanol industry in order to help producers reduce the amount of glucoamylase needed in fermentation and also to provide a substantial yield increase through the introduction of this glycerol reduction pathway. Since that introduction over 50 plants have utilized the TransFerm platform producing over 4 Billion gallons of ethanol.
To learn more about TransFerm Yield+, please click here.